Suppr超能文献

中性粒细胞/淋巴细胞比值与 CA19-9 联合术前评分系统预测行根治性肝切除术的肝内胆管细胞癌患者的长期预后。

The preoperative scoring system combining neutrophil/lymphocyte ratio and CA19-9 predicts the long-term prognosis of intrahepatic cholangiocarcinoma patients undergoing curative liver resection.

机构信息

Department of Hepatic Surgery II, the Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), No. 225, Changhai Road, Yangpu District, Shanghai, 200438, People's Republic of China.

Department of Hepatic Surgery IV, the Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, People's Republic of China.

出版信息

BMC Cancer. 2024 Sep 5;24(1):1106. doi: 10.1186/s12885-024-12819-0.

Abstract

BACKGROUND

This study aims to investigate preoperative prognostic factors available for intrahepatic cholangiocarcinoma (ICC) patients and propose a new preoperative prognostic scoring system for ICC that combines CA19-9 and neutrophil/lymphocyte ratio (NLR).

METHODS

In this retrospective analysis, 1728 patients diagnosed with ICC and undergoing curative liver resections were studied. This study employed univariate and multivariate Cox regression to find factors affecting recurrence and overall survival (OS), and furthermore assessed how preoperative models influenced tumor traits and postoperative recurrence.

RESULTS

The results of the multivariate Cox regression analysis indicated that two preoperative variables, NLR and Ca19-9, were independent risk factors affecting postoperative recurrence and OS in ICC patients. Based on this data, assigning a score of 0 (NLR ≤ 2.4 and Ca19-9 ≤ 37U/ml) or 1 (NLR > 2.4 and Ca19-9 > 37U/ml) to these two factors, a preoperative prognostic score was derived. According to the scoring model, patients were divided into three groups: 0 points (low-risk group), 1 point (intermediate-risk group), and 2 points (high-risk group). The 5-year recurrence and OS rates for the three groups were 56.6%, 68.2%, 77.8%, and 56.8%, 40.6%, 27.6%, respectively, with all P values < 0.001. Furthermore, high-risk group patients were more prone to early recurrence (early recurrence rates for high-, intermediate-, and low-risk groups were 56.8%, 51.5%, and 37.1%, respectively, P < 0.001) and extrahepatic metastasis (extrahepatic metastasis rates for high-, intermediate-, and low-risk groups were 31.7%, 26.4%, and 15.4%, respectively, P < 0.001). In terms of tumor characteristics, high-risk group patients had larger tumor diameters and were more likely to experience microvascular invasion, lymph node metastasis, and perineural invasion.

CONCLUSIONS

The predictive capacity of postoperative recurrence and OS rates in ICC patients is effectively captured by the preoperative scoring system incorporating NLR and CA19-9 levels.

摘要

背景

本研究旨在探讨肝内胆管癌(ICC)患者的术前预后因素,并提出一种新的术前预后评分系统,该系统结合 CA19-9 和中性粒细胞/淋巴细胞比值(NLR)。

方法

本回顾性分析纳入了 1728 例接受根治性肝切除术的 ICC 患者。采用单因素和多因素 Cox 回归分析寻找影响复发和总生存(OS)的因素,并进一步评估术前模型如何影响肿瘤特征和术后复发。

结果

多因素 Cox 回归分析结果表明,NLR 和 Ca19-9 是影响 ICC 患者术后复发和 OS 的独立危险因素。基于此数据,将这两个因素赋值 0 分(NLR≤2.4 和 Ca19-9≤37U/ml)或 1 分(NLR>2.4 和 Ca19-9>37U/ml),得出术前预后评分。根据评分模型,患者被分为三组:0 分(低危组)、1 分(中危组)和 2 分(高危组)。三组的 5 年复发率和 OS 率分别为 56.6%、68.2%、77.8%和 56.8%、40.6%、27.6%,所有 P 值均<0.001。此外,高危组患者更易早期复发(高危组、中危组和低危组的早期复发率分别为 56.8%、51.5%和 37.1%,P<0.001)和肝外转移(高危组、中危组和低危组的肝外转移率分别为 31.7%、26.4%和 15.4%,P<0.001)。在肿瘤特征方面,高危组患者的肿瘤直径更大,更易发生微血管侵犯、淋巴结转移和神经侵犯。

结论

NLR 和 CA19-9 水平联合的术前评分系统能有效预测 ICC 患者术后复发和 OS 率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3144/11378368/ff8371edaeff/12885_2024_12819_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验